Hospital, Pharmacy, and Outpatient Costs for Osteoarthritis and Chronic Back Pain

Journal of Rheumatology

Volumn 31, Issue 3, 2004, Pages 573-583

  Mapel, Douglas W ^a,b   Shainline, Michael ^a   Paez, Kathy ^a   Gunter, Margaret ^a  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Chronic back pain; Cost economic evaluation; Osteoarthritis; Utilization

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; CORTICOSTEROID; HORMONE; LIPOTROPIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AGE; AGED; ARTICLE; BACKACHE; CASE CONTROL STUDY; CHRONIC PAIN; CONTROLLED STUDY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; OSTEOARTHRITIS; OUTPATIENT CARE; PHARMACEUTICAL CARE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMBULATORY CARE; BACK PAIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; DRUG COSTS; FEMALE; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; NEW MEXICO; OSTEOARTHRITIS; PREVALENCE;

EID: 1542724880     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Reginster JY. The prevalence and burden of arthritis. Rheumatology 2002;41 Suppl 1:3-6.
2. Centers for Disease Control. Prevalence of arthritis - United States, 1997. MMWR Morb Mortal Wkly Rep 2001;50:334-6.
3. Centers for Disease Control. Prevalence of disabilities and associated health conditions - United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:120-5.
4. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Advance data from vital and health statistics; No. 328. Hyattsville, MD: National Center for Health Statistics; 2002.
5. Ruof J, Hülsemann JL, Stucki G. Evaluation of costs in rheumatic diseases: a literature review. Curr Opin Rheumatol 1999;11:104-9.
6. Fautrel B, Guillemin F. Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 2002;14:121-6.
7. Arthritis and Osteoporosis Prevention and Control Programs, New Mexico Department of Health; The State of Arthritis in New Mexico 2003. Albuquerque: New Mexico Department of Health; 2003.
8. Byrnes JJ, Shainline M, Lucas J, Gunter MJ. Lovelace Health Systems: restructuring for quality. In: Boland P, editor. Redesigning healthcare delivery. Berkeley, CA: Boland Healthcare; 1996:482-501,
9. Howard CA, Samet JM, Buechley RW, Schrag SD, Key CR. Survey research in New Mexico Hispanics: some methodological issues. Am J Epidemiol 1983;117:27-34.
10. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9 administrative databases. J Clin Epidemiol 1992;45:613-9.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
12. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley & Sons; 1981,
13. Zhou XH, Melfi CA, Hui SL. Methods for comparison of cost data. Ann Intern Med 1997;127:752-6.
14. Coyle D, Welch V, Shea B, Gabriel S, Drummond M, Tugwell P. Issues of consensus and debate for economic evaluation in rheumatology. J Rheumatol 2001;28:642-7.
15. Gabriel S, Drummond M, Suarez-Almazor ME, et al. OMERACT 5 Economics Working Group: summary, recommendations, and research agenda. J Rheumatol 2001;28:670-3.
16. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
17. Lanes SF, Lanza LL, Radensky PW, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
18. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000;84:95-103.
19. McGuirk B, King W, Govind J, Lowry J, Bogduk N. Safety, efficacy, and cost effectiveness of evidence-based guidelines for the management of acute low back pain in primary care. Spine 2001;26:2615-22.
20. Cherkin DC, Deyo RA, Battie M, Street J, Barlow W. A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med 1998;339:1021-9.
21. Stano M, Haas M, Goldberg B, Traub PM, Nyiendo J. Chiropractic and medical care costs of low back care: results from a practice-based observational study. Am J Manag Care 2002;8:802-9.
22. Stano M, Smith M. Chiropractic and medical costs of low back care. Med Care 1996;34:191-204.
23. Shekelle PG, Markovich M, Louie R. Comparing the costs between provider types of episodes of back pain care. Spine 1995;20:221-7.
24. Mushinski M. Average hospital charges for medical and surgical treatment of back problems: United States, 1993. Stat Bull Metrop Insur Co 1995;76:26-35.
25. Taylor TN, Namjoshi M, Redford T. Drug utilization and expenditures for individuals with low back pain: an analysis of Medicaid data. J Res Pharm Econ 1998;9:47-56.